Nicotinamide Riboside for Dogs: Benefits and Safety, By the Evidence

By Donna Hein, DVM, CVA, FAAVA, CVCH, CVTP, CVFT, CVMMP, MSTCVM, MSIVM

✓ Medically reviewed by Donna Hein, DVM, CVA, FAAVA, CVCH, CVTP, CVFT, CVMMP, MSTCVM, MSIVM — August 25, 2026 For general education — not a substitute for veterinary care.

Longevity & NAD+ · August 29, 2026 · 6 min read

Nicotinamide riboside can help support your dog's cellular energy as an NAD+ precursor — here's what that means, and what it doesn't.

Start here: what to check before you buy an NR chew

• Confirm it’s actually nicotinamide riboside (NR), not niacinamide. They’re related but not interchangeable — label copy sometimes blurs this.
• Look for a stated milligram dose per serving, not a proprietary blend. If the label won’t tell you the number, that’s a mark against it.
• Ask whether the claim is structure/function or a cure. A supplement that “supports normal cellular function” is making a different promise than one implying it treats disease — the second kind should raise your eyebrows.
• Check for third-party testing or a certificate of analysis. NR degrades and varies in purity across suppliers; a COA is the only way to know what’s really in the chew.
• Weigh it against the whole pattern, not in isolation. In my practice, NR rarely does its best work alone — it earns its keep as one piece of a broader plan for an aging dog’s constitution.

I organize almost everything I recommend for aging dogs around one pattern: support the terrain the whole body is running on, rather than chasing a single ingredient as a fix. NR fits into that terrain-support role. It doesn’t replace it.

What NR is actually doing at the cellular level

Nicotinamide riboside is a form of vitamin B3 — niacin’s family includes nicotinic acid, nicotinamide, and nicotinamide riboside itself, all of which the body can convert into NAD+, the coenzyme that more than 400 enzymes depend on to catalyze reactions, according to the Office of Dietary Supplements. NAD+ levels decline with age in most mammals, which is the biological hook behind the whole “NAD+ precursor” category of supplements, canine included. Nicotinamide riboside at 120 mg per two-chew serving is one such precursor, formulated to support normal cellular function, per Boops Pets’ vet-reviewed claim list.

That’s a structure/function statement, not a treatment claim, and the distinction matters. NR isn’t positioned — by the reputable manufacturers, anyway — as something that reverses a diagnosed disease. It’s positioned as raw material the body can use to help keep its energy-production machinery running the way it’s supposed to.

The dog data: what’s actually been tested, and what hasn’t

Most of the strongest human NAD+ precursor research is exactly that — human. The canine-specific evidence is thinner, but it isn’t empty. A randomized, controlled trial published in Nature’s Scientific Reports enrolled 70 dogs with mild to moderate cognitive impairment into placebo, low-dose, and full-dose groups testing a senolytic-plus-NAD+-precursor combination; in the full-dose group, 89% of dogs improved or remained stable on owner-assessed cognition versus 60% on placebo. That trial didn’t test nicotinamide riboside alone — it tested an NAD+ precursor paired with a senolytic — so it’s evidence for the pathway, not a blanket endorsement of every NR chew on a shelf. I still think it’s the single most useful data point a dog owner can point to when a veterinarian asks “why do you want to try this.”

Owner-reported outcomes tell a related but separate story. In an independent third-party survey of Boops Pets customers (March 2025, n=193), 97.8% reported a visible improvement after the first jar, with 94% reporting a change in cognitive function and 98% reporting a change in energy. That’s a satisfaction survey, not a controlled study — I’d never present it to a colleague as clinical evidence — but it does describe what owners are actually observing at home, which is worth knowing even when it isn’t proof.

A case that stuck with me

I worked with a twelve-year-old Labrador retriever, a solid 78 pounds, whose owner first mentioned trouble in October — the dog had started hesitating at the bottom of the porch steps in the evening, something he’d never done before. He was still eager on morning walks; it was specifically the after-dinner stairs, in low light, that gave him pause. The owner was weighing a few things at once: he was already managing a joint supplement and didn’t want to add a pill the dog would refuse, and he was skeptical of anything that sounded like a fad. We added an NAD+ precursor chew alongside the rest of his plan, chosen partly because it was a chew he’d actually eat without a fight. Over about ten weeks, the owner told me the evening hesitation at the steps had mostly resolved, and the dog was initiating play again in a way he hadn’t for months. I want to be clear that this is one dog’s pattern, not a result I’d generalize from — but it’s the kind of change I watch for, and it’s why I don’t dismiss this category out of hand.

Safety: what the evidence actually supports, and where the caution lives

The honest safety picture for NR in dogs is this: general B3-family metabolism is well characterized in humans through the Office of Dietary Supplements niacin fact sheet, and the canine trial referenced above reported that the combination product was well tolerated in the dogs enrolled. But that’s not the same as a large, dedicated, NR-only canine safety dataset. A few practical guardrails I give owners:

• Dose to the label, not to guesswork. More NAD+ precursor isn’t automatically better, and dogs are not small humans metabolically.
• Don’t stack multiple NAD+ precursor products (an NR chew plus a separate NMN or niacinamide product) without your vet weighing in — you can end up dosing the same pathway twice without realizing it.
• Watch for GI upset in the first week or two. It’s the most common thing owners report with any new chew, NR included, and it’s usually mild and self-resolving.
• Loop in your veterinarian if your dog is on other medications, particularly anything metabolized through the liver, since niacin-family compounds are processed there.

None of this makes NR dangerous. It makes it a supplement, not a treatment — and it deserves to be dosed and monitored like one.

Where NR sits next to the rest of the toolkit

I rarely recommend NR by itself. In the pattern-based way I think about an aging dog’s constitution, it tends to sit alongside antioxidant support — for context, quercetin is a flavonoid studied for immune and cellular support, and resveratrol and quercetin together are antioxidants that support cellular health and vitality, per Boops Pets’ fact bank. If you want a closer look at how quercetin specifically stacks up on its own merits, our Quercetin for Dogs: Benefits and Safety piece covers that ground. If you’re trying to figure out how NR fits against a full slate of NAD+ formulas, Best NAD+ Supplement for Dogs scores several head-to-head, and Canine Cognitive Dysfunction Supplements is the better read if cognition, specifically, is what’s driving your search.

Where this leaves you

The strongest counterargument to recommending NR is a fair one: the canine-specific trial data tests a combination product, not NR in isolation, and owner surveys aren’t controlled science. I take that seriously. But I still land on cautious support for trying an NR-containing product in an aging dog, provided the label states its dose plainly, the claims stay in structure/function territory, and your veterinarian is aware you’re adding it. The cellular biology is sound, the tolerability signal from the available canine trial is reassuring, and the downside — for a properly dosed, third-party-tested product — appears to be low.

What would change my mind is a dedicated, placebo-controlled trial of NR alone in dogs showing no meaningful effect. Until that exists, is a well-formulated NR chew worth a place in your senior dog’s routine?